Management of hyperglycaemia in type 2 diabetes: a clinician's algorithm

Abstract

Get full access to this article

View all access options for this article.

References

Nathan DM , Buse JB , Davidson MB et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2006;49:1711-21.

Nathan DM , Buse JB , Davidson MB et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia 2008;51:8-11.

N .Bailey CJ , Day C. , Campbell IW A consensus algorithm for treating hyperglycaemia in type 2 diabetes. Br J Diabetes Vasc Dis 2006;6:147-8.

Feher MD , Al- Mrayat M. , Brake J. , Leong K. Tolerability of prolonged-release metformin (Glucophage® SR) in individuals intolerant to standard metformin. Results from four UK centres. Br J Diabetes Vasc Dis 2007;7:225-8.

Day C. New therapies available for the treatment of diabetes. Eur Diabetes Nursing 2006;3:65-70.

Munro N. , Levy J. Gut hormones, incretin mimetics and gliptins: New understanding and novel therapies in type 2 diabetes. Primary Care Diabetes 2007;1:103-05.

Munro N. , Levy J. , El- Gayer H. , Feher M. New therapies for diabetes: Incretin mimetics and gliptins. Diabetes and Primary Care 2007;9:72-80.